Compounds > n-methyl-3,4-methylenedioxyamphetamine

n-methyl-3,4-methylenedioxyamphetamine and tetrodotoxin

n-methyl-3,4-methylenedioxyamphetamine has been researched along with tetrodotoxin in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (60.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Gudelsky, GA; Nash, JF; Yamamoto, BK1
Fadayel, GM; Schmidt, CJ; Sullivan, CK1
Gudelsky, GA; Nash, JF1
Anneken, JH; Gudelsky, GA1
Ben Hamida, S; Cassel, JC; Cosquer, B; Jones, BC; Lecourtier, L; Loureiro, M; Nehlig, A; Pereira de Vasconcelos, A; Simmoneaux, V; Tracqui, A1

Other Studies

5 other study(ies) available for n-methyl-3,4-methylenedioxyamphetamine and tetrodotoxin

ArticleYear
Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra.
    The Journal of pharmacology and experimental therapeutics, 1995, Volume: 273, Issue:3

    Topics: Animals; Corpus Striatum; Dextroamphetamine; gamma-Aminobutyric Acid; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Serotonin; Substantia Nigra; Tetrodotoxin

1995
Blockade of striatal 5-hydroxytryptamine2 receptors reduces the increase in extracellular concentrations of dopamine produced by the amphetamine analogue 3,4-methylenedioxymethamphetamine.
    Journal of neurochemistry, 1994, Volume: 62, Issue:4

    Topics: 3,4-Dihydroxyphenylacetic Acid; 3,4-Methylenedioxyamphetamine; Animals; Corpus Striatum; Dialysis; Dopamine; Extracellular Space; Fluorobenzenes; Homovanillic Acid; Kinetics; N-Methyl-3,4-methylenedioxyamphetamine; Piperidines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin Antagonists; Tetrodotoxin

1994
Carrier-mediated release of serotonin by 3,4-methylenedioxymethamphetamine: implications for serotonin-dopamine interactions.
    Journal of neurochemistry, 1996, Volume: 66, Issue:1

    Topics: 5-Hydroxytryptophan; Animals; Carbidopa; Carrier Proteins; Corpus Striatum; Dopamine; Drug Synergism; Fluoxetine; Frontal Lobe; Male; Membrane Glycoproteins; Membrane Transport Proteins; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Tissue Proteins; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins; Tetrodotoxin

1996
MDMA produces a delayed and sustained increase in the extracellular concentration of glutamate in the rat hippocampus.
    Neuropharmacology, 2012, Volume: 63, Issue:6

    Topics: Adrenergic Uptake Inhibitors; Animals; Chromatography, High Pressure Liquid; Extracellular Space; Fluoxetine; Glutamic Acid; Hippocampus; Ketanserin; Male; Microdialysis; N-Methyl-3,4-methylenedioxyamphetamine; Neostriatum; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sodium Channel Blockers; Tetrodotoxin

2012
Ventral striatum regulates behavioral response to ethanol and MDMA combination.
    Addiction biology, 2021, Volume: 26, Issue:2

    Topics: Animals; Drug Combinations; Drug Synergism; Ethanol; Locomotion; Male; N-Methyl-3,4-methylenedioxyamphetamine; Oxidopamine; Rats; Rats, Long-Evans; Receptors, Dopamine D1; Receptors, N-Methyl-D-Aspartate; Tetrodotoxin; Ventral Striatum

2021